For following the competition: what moved in each program, several studies read as one move.
- METTL3 inhibitor STC-15
- EP2/EP4/DP1 Antagonist OKN4395
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Leiomyosarcoma to watchlistEvery Monday by email · turn it off any timePro · free during the beta